Inactive

Notice of Intent to Sole Source THIS IS A NOTICE OF INTENT TO AWARD A SOLE SOURCE CONTRACT AND IS NOT A REQUEST FOR COMPETITIVE QUOTES. Reference#: N0025921N0042. Naval Medical Center San Diego (NMCSD... Notice of Intent to Sole Source THIS IS A NOTICE OF INTENT TO AWARD A SOLE SOURCE CONTRACT AND IS NOT A REQUEST FOR COMPETITIVE QUOTES. Reference#: N0025921N0042. Naval Medical Center San Diego (NMCSD) intends to award a firm fixed price sole source contract under the authority of FAR 13.106-1(b)(1)(i), only one source being available to meet the Government’s needs, to: Ethicon US LLC 4545 Creek Rd. ML#3 Cincinnati, OH 45242-2803 The North American Industry Classification System (NAICS) code for this requirement is 339113; the business size standard is 750 (# of employees). The objective of this sole source award is to provide the following supplies for (28) Vistaseal Fibrin Based Hemostatic Agent with the following characteristics: CLIN 0001: Vistaseal 12VST10 Total Quantity: 28 Unit of Issue: Kit Ethicon is the only vendor that can provide the fibrin based hemostatic application for emergent hemorrhagic controls currently in use at Naval Medical Center San Diego. This notice of intent is not a request for competitive proposals and no solicitation document exists for the requirement. Sources interested in responding to this notice are required to submit a capability statement that includes management and technical data and cost information, in sufficient detail and with convincing evidence that clearly demonstrates the capability to perform the required work and are able to provide valid certification to provide service validated by Ethicon US LLC. Capability statements shall not exceed 6 (8.5 x 11 inch) pages using a font size no smaller than 10-point. All capability statements received by the due date of this notice will be considered by the Government. A request for documentation or additional information or submissions that only ask questions will not be considered as an affirmative response. A determination by the Government not to compete based on responses to this notice is solely within the discretion of the Government. Information received will be considered solely for the purpose of determining whether to conduct a competitive procurement or to proceed with a sole source purchase order. Capability statements are due by 1000 Pacific Time, 10 April 2021. Capability statements shall be submitted by e-mail ONLY as a Microsoft Word or Adobe PDF attachment to the following address: dernell.w.wade.civ@mail.mil. The email subject line shall state, “Naval Medical Center San Diego, Special Notice Number N0025921N0042.” NO TELEPHONE REQUESTS/OFFERS WILL BE HONORED

Inactive

Notice of Intent to Sole Source THIS IS A NOTICE OF INTENT TO AWARD A SOLE SOURCE CONTRACT AND IS NOT A REQUEST FOR COMPETITIVE QUOTES. Reference#: N0025921N0042. Naval Medicine Readiness and Training... Notice of Intent to Sole Source THIS IS A NOTICE OF INTENT TO AWARD A SOLE SOURCE CONTRACT AND IS NOT A REQUEST FOR COMPETITIVE QUOTES. Reference#: N0025921N0042. Naval Medicine Readiness and Training Command San Diego (NMRTCSD) intends to award a firm fixed price contract under the authority of FAR 13.106-1(b)(1)(i), only one source being available to meet the Government’s needs, to: TERUMO BCT, INC. 10811 W. Collins Avenue Lakewood, CO 80215-4440 The North American Industry Classification System (NAICS) code for this requirement is 811219; the business size standard is 22.0 (millions of dollars). The objective of this sole source award is to procure an Annual Service Maintenance Agreement (SMA) for (2) Terumo Spectra Optia Apheresis Machines. Period of performance: 29 Apr 2021- 28 Apr 2022, with three (3) additional option years. Terumo BCT, Inc. is the original equipment manufacturer and therefore, the technicians performing the service maintenance are certified to work on the equipment. Terumo BCT, Inc. is the only source that can provide the service maintenance required. Due to the proprietary nature of equipment, no other company was found that has authorized third-party service providers. This notice of intent is not a request for competitive proposals and no solicitation document exists for the requirement. Sources interested in responding to this notice are required to submit a capability statement that includes management and technical data and cost information, in sufficient detail and with convincing evidence that clearly demonstrates the capability to supply the required service maintenance for the Terumo Spectra Optia Apheresis Machines validated by Terumo BCT, Inc. Capability statements shall not exceed 6 (8.5 x 11 inch) pages using a font size no smaller than 10-point. All capability statements received by the due date of this notice will be considered by the Government. A request for documentation or additional information or submissions that only ask questions will not be considered as an affirmative response. A determination by the Government not to compete based on responses to this notice is solely within the discretion of the Government. Information received will be considered solely for the purpose of determining whether to conduct a competitive procurement or to proceed with a sole source purchase order. Capability statements are due by 12:00 PM pacific time, March 31, 2021. Capability statements shall be submitted by e-mail ONLY as a Microsoft Word or Adobe PDF attachment to the following address: mildred.k.pollard-hueitt.civ@mail.mil . The email subject line shall state, “Naval Medicine Readiness and Training Command San Diego, Special Notice Number N0025921N0042.” NO TELEPHONE REQUESTS/OFFERS WILL BE HONORED